drugset / Trial / NCT04459754
Fuzheng Yiliu-1010
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Real world study was used to evaluate the therapeutic effect of Fuzheng anti-tumor therapy on colorectal cancer patients in stage II and III after surgery and standard chemotherapy, and the prediction model of dominant population of Fuzheng anti-tumor therapy was constructed by using real-world data and gene expression profile data.
Timeline
- Start
- 2020-06-29
- Primary completion
- 2021-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fuzheng Yiliu Formulation | Traditional medicine (herbal / TCM) | — | — |